Taro Ohba

873 total citations
23 papers, 697 citations indexed

About

Taro Ohba is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Taro Ohba has authored 23 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Taro Ohba's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Taro Ohba is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Taro Ohba collaborates with scholars based in Japan. Taro Ohba's co-authors include Yoshihiko Maehara, Tomoyoshi Takenaka, Fumihiro Shoji, Ichiro Yoshino, Hidenori Kouso, Takuro Kometani, Naoko Miura, Tokujiro Yano, Tomofumi Yohena and Atsushi Osoegawa and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Cancer Research.

In The Last Decade

Taro Ohba

22 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taro Ohba Japan 14 342 333 286 151 63 23 697
You‐cai Zhu China 15 307 0.9× 250 0.8× 222 0.8× 138 0.9× 39 0.6× 59 533
Dan Sun China 14 214 0.6× 209 0.6× 323 1.1× 173 1.1× 140 2.2× 27 709
Masato Terashima Japan 19 358 1.0× 397 1.2× 452 1.6× 215 1.4× 54 0.9× 35 844
Huilin Xu China 14 174 0.5× 325 1.0× 113 0.4× 96 0.6× 45 0.7× 38 515
Elisabeth Smolle Austria 12 154 0.5× 146 0.4× 329 1.2× 237 1.6× 73 1.2× 21 639
Gabriel Olmedilla Spain 12 239 0.7× 125 0.4× 237 0.8× 132 0.9× 55 0.9× 17 556
Ione Tamagnini Italy 13 249 0.7× 325 1.0× 269 0.9× 141 0.9× 80 1.3× 24 720
Tingting Zhao China 17 143 0.4× 177 0.5× 278 1.0× 224 1.5× 89 1.4× 35 672
M Paesmans Belgium 5 196 0.6× 225 0.7× 159 0.6× 75 0.5× 46 0.7× 6 455
Cheng Tang China 15 158 0.5× 164 0.5× 196 0.7× 117 0.8× 142 2.3× 40 516

Countries citing papers authored by Taro Ohba

Since Specialization
Citations

This map shows the geographic impact of Taro Ohba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Ohba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Ohba more than expected).

Fields of papers citing papers by Taro Ohba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Ohba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Ohba. The network helps show where Taro Ohba may publish in the future.

Co-authorship network of co-authors of Taro Ohba

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Ohba. A scholar is included among the top collaborators of Taro Ohba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Ohba. Taro Ohba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takamori, Shinkichi, Taro Ohba, Mototsugu Shimokawa, et al.. (2021). Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study). PLoS ONE. 16(10). e0258616–e0258616. 1 indexed citations
2.
Ohba, Taro, Shinkichi Takamori, Ryo Toyozawa, et al.. (2019). Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumab. Journal of Thoracic Disease. 11(9). 3757–3768. 33 indexed citations
3.
Haratake, Naoki, Takashi Seto, Shinkichi Takamori, et al.. (2019). Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients. Thoracic Cancer. 10(9). 1779–1787. 6 indexed citations
4.
Ohba, Taro, Gouji Toyokawa, Atsushi Osoegawa, et al.. (2015). Mutations of the EGFR, K-ras, EML4–ALK, and BRAF genes in resected pathological stage I lung adenocarcinoma. Surgery Today. 46(9). 1091–1098. 19 indexed citations
5.
Yamaguchi, Masafumi, Gouji Toyokawa, Taro Ohba, et al.. (2013). Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 96(5). 1783–1789. 17 indexed citations
6.
Ohba, Taro, Gouji Toyokawa, Takuro Kometani, et al.. (2013). The mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance. Surgery Today. 44(3). 478–486. 26 indexed citations
7.
Toyokawa, Gouji, Kenichi Taguchi, Taro Ohba, et al.. (2012). First Case of Combined Small-Cell Lung Cancer with Adenocarcinoma Harboring EML4 - ALK Fusion and an Exon 19 EGFR Mutation in Each Histological Component. Journal of Thoracic Oncology. 7(12). e39–e41. 42 indexed citations
8.
Toyokawa, Gouji, Kenichi Taguchi, Taro Ohba, et al.. (2012). Regression of thymoma associated with a multilocular thymic cyst: report of a case. Surgery Today. 44(3). 577–580. 5 indexed citations
9.
Ohba, Taro, Kenji Sugio, Takuro Kometani, et al.. (2011). Signet ring cell adenocarcinoma of the lung with an EML4–ALK fusion gene mimicking mucinous (colloid) adenocarcinoma: A case report. Lung Cancer. 73(3). 375–378. 3 indexed citations
10.
Yohena, Tomofumi, Ichiro Yoshino, Tomoyoshi Takenaka, et al.. (2009). Upregulation of Hypoxia-Inducible Factor-1α mRNA and its Clinical Significance in Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(3). 284–290. 47 indexed citations
11.
Kometani, Takuro, Ichiro Yoshino, Naoko Miura, et al.. (2009). Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway. Cancer Letters. 278(1). 27–33. 49 indexed citations
12.
Takenaka, Tomoyoshi, Tokujiro Yano, Chikako Kiyohara, et al.. (2009). Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients. Lung Cancer. 67(1). 101–107. 62 indexed citations
13.
Ohba, Taro, Fumihiro Shoji, Tokujiro Yano, et al.. (2009). Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 677(1-2). 66–71. 11 indexed citations
14.
Kouso, Hidenori, Ichiro Yoshino, Naoko Miura, et al.. (2008). Expression of mismatch repair proteins, hMLH1/hMSH2, in non‐small cell lung cancer tissues and its clinical significance. Journal of Surgical Oncology. 98(5). 377–383. 16 indexed citations
15.
Yano, Tokujiro, Naoko Miura, Tomoyoshi Takenaka, et al.. (2008). Never‐smoking nonsmall cell lung cancer as a separate entity. Cancer. 113(5). 1012–1018. 107 indexed citations
16.
Ohba, Taro, et al.. (2008). Schwannoma in the peridiaphragm. General Thoracic and Cardiovascular Surgery. 56(9). 453–455. 7 indexed citations
17.
Hamatake, Motoharu, Ichiro Yoshino, Naoko Miura, et al.. (2008). Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer. Surgery Today. 38(10). 921–925. 7 indexed citations
18.
Yoshino, Ichiro, Takuro Kometani, Fumihiro Shoji, et al.. (2007). Induction of epithelial‐mesenchymal transition‐related genes by benzo[a]pyrene in lung cancer cells. Cancer. 110(2). 369–374. 69 indexed citations
19.
Takenaka, Tomoyoshi, Ichiro Yoshino, Hidenori Kouso, et al.. (2007). Combined evaluation of Rad51 and ERCC1 expressions for sensitivity to platinum agents in non‐small cell lung cancer. International Journal of Cancer. 121(4). 895–900. 101 indexed citations
20.
Shoji, Fumihiro, Ichiro Yoshino, Tokujiro Yano, et al.. (2007). Serum carcinoembryonic antigen level is associated with epidermal growth factor receptor mutations in recurrent lung adenocarcinomas. Cancer. 110(12). 2793–2798. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by You‐cai Zhu Breakdown of academic impact, for papers by Dan Sun Breakdown of academic impact, for papers by Masato Terashima Breakdown of academic impact, for papers by Huilin Xu Breakdown of academic impact, for papers by Elisabeth Smolle Breakdown of academic impact, for papers by Gabriel Olmedilla Breakdown of academic impact, for papers by Ione Tamagnini Breakdown of academic impact, for papers by Tingting Zhao Breakdown of academic impact, for papers by M Paesmans Breakdown of academic impact, for papers by Cheng Tang
Rankless by CCL
2026